ReP USP - Resultado da busca

Artigo de periodico
Topical delivery of seriniquinone for treatment of skin cancer and fungal infections is enabled by a liquid crystalline lamellar phase (2023)
Miguel, Rodrigo dos Anjos ; Hirata, Amanda Soares ; Salata, Giovanna Cassone ; Apolinário, Alexsandra Conceição ; Barroso, Vinícius de Morais ; Clair, James J. La ; Fenical, William ; Martins, Tereza Silva ; Costa-Lotufo, Letícia Veras ; Ishida, Kelly ; Lopes, Luciana Biagini
Source: European Journal of Pharmaceutical Sciences. Unidade: ICB
Subjects: MICROBIOLOGIA, FARMACOLOGIA, CÉLULAS CULTIVADAS DE TUMOR, NEOPLASIAS CUTÂNEAS, ANTINEOPLÁSICOS, MELANOMA, ANIMAIS, CANDIDA ALBICANS, MICOSES, PELE, NANOTECNOLOGIA, ANTIFÚNGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIGUEL, Rodrigo dos Anjos et al. Topical delivery of seriniquinone for treatment of skin cancer and fungal infections is enabled by a liquid crystalline lamellar phase. European Journal of Pharmaceutical Sciences, v. 192, p. 14 , 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2023.106635. Acesso em: 14 nov. 2024.
APA
Miguel, R. dos A., Hirata, A. S., Salata, G. C., Apolinário, A. C., Barroso, V. de M., Clair, J. J. L., et al. (2023). Topical delivery of seriniquinone for treatment of skin cancer and fungal infections is enabled by a liquid crystalline lamellar phase. European Journal of Pharmaceutical Sciences, 192, 14 . doi:10.1016/j.ejps.2023.106635
NLM
Miguel R dos A, Hirata AS, Salata GC, Apolinário AC, Barroso V de M, Clair JJL, Fenical W, Martins TS, Costa-Lotufo LV, Ishida K, Lopes LB. Topical delivery of seriniquinone for treatment of skin cancer and fungal infections is enabled by a liquid crystalline lamellar phase [Internet]. European Journal of Pharmaceutical Sciences. 2023 ; 192 14 .[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.ejps.2023.106635
Vancouver
Miguel R dos A, Hirata AS, Salata GC, Apolinário AC, Barroso V de M, Clair JJL, Fenical W, Martins TS, Costa-Lotufo LV, Ishida K, Lopes LB. Topical delivery of seriniquinone for treatment of skin cancer and fungal infections is enabled by a liquid crystalline lamellar phase [Internet]. European Journal of Pharmaceutical Sciences. 2023 ; 192 14 .[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.ejps.2023.106635
Artigo de periodico
Preclinical development of seriniquinones as selective dermcidin modulators for the treatment of melanoma (2022)
Hirata, Amanda Soares ; Clair, James J. La ; Jimenez, Paula C. ; Costa-Lotufo, Letícia Veras ; Fenical, William
Source: Marine Drugs. Unidade: ICB
Subjects: FARMACOLOGIA, CÉLULAS CULTIVADAS DE TUMOR, APOPTOSE, PRODUTOS NATURAIS, MELANOMA, NEOPLASIAS CUTÂNEAS, MOLÉCULA, INFECÇÕES BACTERIANAS GRAM-POSITIVAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Amanda Soares et al. Preclinical development of seriniquinones as selective dermcidin modulators for the treatment of melanoma. Marine Drugs, v. 20, n. 5, p. 1-13, 2022Tradução . . Disponível em: https://doi.org/10.3390/md20050301. Acesso em: 14 nov. 2024.
APA
Hirata, A. S., Clair, J. J. L., Jimenez, P. C., Costa-Lotufo, L. V., & Fenical, W. (2022). Preclinical development of seriniquinones as selective dermcidin modulators for the treatment of melanoma. Marine Drugs, 20( 5), 1-13. doi:10.3390/md20050301
NLM
Hirata AS, Clair JJL, Jimenez PC, Costa-Lotufo LV, Fenical W. Preclinical development of seriniquinones as selective dermcidin modulators for the treatment of melanoma [Internet]. Marine Drugs. 2022 ; 20( 5): 1-13.[citado 2024 nov. 14 ] Available from: https://doi.org/10.3390/md20050301
Vancouver
Hirata AS, Clair JJL, Jimenez PC, Costa-Lotufo LV, Fenical W. Preclinical development of seriniquinones as selective dermcidin modulators for the treatment of melanoma [Internet]. Marine Drugs. 2022 ; 20( 5): 1-13.[citado 2024 nov. 14 ] Available from: https://doi.org/10.3390/md20050301
Artigo de periodico
Seriniquinones as therapeutic leads for treatment of BRAF and NRAS mutant melanomas (2021)
Hirata, Amanda Soares ; Teixeira, Paula Rezende ; Machado Neto, João Agostinho ; Jimenez, Paula C. ; Clair, James J. La ; Fenical, William ; Costa-Lotufo, Letícia Veras
Source: Molecules. Unidade: ICB
Subjects: FARMACOLOGIA, APOPTOSE, PRODUTOS NATURAIS, PEPTÍDEOS, AMINOÁCIDOS, CÉLULAS CULTIVADAS DE TUMOR, MELANOMA, MOLÉCULA, BACTÉRIAS AERÓBICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Amanda Soares et al. Seriniquinones as therapeutic leads for treatment of BRAF and NRAS mutant melanomas. Molecules, v. 26, n. 23, p. 1-15, 2021Tradução . . Disponível em: https://doi.org/10.3390/molecules26237362. Acesso em: 14 nov. 2024.
APA
Hirata, A. S., Teixeira, P. R., Machado Neto, J. A., Jimenez, P. C., Clair, J. J. L., Fenical, W., & Costa-Lotufo, L. V. (2021). Seriniquinones as therapeutic leads for treatment of BRAF and NRAS mutant melanomas. Molecules, 26( 23), 1-15. doi:10.3390/molecules26237362
NLM
Hirata AS, Teixeira PR, Machado Neto JA, Jimenez PC, Clair JJL, Fenical W, Costa-Lotufo LV. Seriniquinones as therapeutic leads for treatment of BRAF and NRAS mutant melanomas [Internet]. Molecules. 2021 ; 26( 23): 1-15.[citado 2024 nov. 14 ] Available from: https://doi.org/10.3390/molecules26237362
Vancouver
Hirata AS, Teixeira PR, Machado Neto JA, Jimenez PC, Clair JJL, Fenical W, Costa-Lotufo LV. Seriniquinones as therapeutic leads for treatment of BRAF and NRAS mutant melanomas [Internet]. Molecules. 2021 ; 26( 23): 1-15.[citado 2024 nov. 14 ] Available from: https://doi.org/10.3390/molecules26237362
Artigo de periodico
Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline (2020)
Apolinário, Alexsandra Conceição ; Hirata, Amanda Soares ; Miguel, Rodrigo dos Anjos ; Costa-Lotufo, Letícia Veras ; Pessoa Junior, Adalberto ; Clair, James J. La ; Fenical, William ; Lopes, Luciana Biagini
Source: Nanomedicine. Unidades: ICB, FCF
Subjects: FARMACOLOGIA, NEOPLASIAS MAMÁRIAS, NANOTECNOLOGIA, ANTINEOPLÁSICOS, QUIMIOTERÁPICOS, MELANOMA, FARMACOS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
APOLINÁRIO, Alexsandra Conceição et al. Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline. Nanomedicine, v. 15, n. 26, p. 2539–2542, 2020Tradução . . Disponível em: https://doi.org/10.2217/nnm-2020-0290. Acesso em: 14 nov. 2024.
APA
Apolinário, A. C., Hirata, A. S., Miguel, R. dos A., Costa-Lotufo, L. V., Pessoa Junior, A., Clair, J. J. L., et al. (2020). Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline. Nanomedicine, 15( 26), 2539–2542. doi:10.2217/nnm-2020-0290
NLM
Apolinário AC, Hirata AS, Miguel R dos A, Costa-Lotufo LV, Pessoa Junior A, Clair JJL, Fenical W, Lopes LB. Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline [Internet]. Nanomedicine. 2020 ; 15( 26): 2539–2542.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2217/nnm-2020-0290
Vancouver
Apolinário AC, Hirata AS, Miguel R dos A, Costa-Lotufo LV, Pessoa Junior A, Clair JJL, Fenical W, Lopes LB. Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline [Internet]. Nanomedicine. 2020 ; 15( 26): 2539–2542.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2217/nnm-2020-0290
Trabalho de evento-resumo periodico
Seriniquinone, metabolite from a marine bacterium, and its synthetic derivative for melanoma and resistant melanoma cells treatment (2020)
Hirata, Amanda S. ; Branco, Paola C. ; Rezende-Teixeira, Paula ; Jimenez, Paula C. ; Clair, James J. La ; Fenical, William ; Costa-Lotufo, Letícia Veras
Source: Marine Drugs. Conference titles: International Symposium on Marine Natural Products. Unidade: ICB
Subjects: METABÓLITOS SECUNDÁRIOS, PRODUTOS NATURAIS, EXPRESSÃO GÊNICA, REGULAÇÃO GÊNICA, MELANOMA, CÉLULAS CULTIVADAS DE TUMOR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Amanda S. et al. Seriniquinone, metabolite from a marine bacterium, and its synthetic derivative for melanoma and resistant melanoma cells treatment. Marine Drugs. Basel: MDPI AG. Disponível em: https://doi.org/10.3390/md18010040. Acesso em: 14 nov. 2024. , 2020
APA
Hirata, A. S., Branco, P. C., Rezende-Teixeira, P., Jimenez, P. C., Clair, J. J. L., Fenical, W., & Costa-Lotufo, L. V. (2020). Seriniquinone, metabolite from a marine bacterium, and its synthetic derivative for melanoma and resistant melanoma cells treatment. Marine Drugs. Basel: MDPI AG. doi:10.3390/md18010040
NLM
Hirata AS, Branco PC, Rezende-Teixeira P, Jimenez PC, Clair JJL, Fenical W, Costa-Lotufo LV. Seriniquinone, metabolite from a marine bacterium, and its synthetic derivative for melanoma and resistant melanoma cells treatment [Internet]. Marine Drugs. 2020 ; 18( 1): 114.[citado 2024 nov. 14 ] Available from: https://doi.org/10.3390/md18010040
Vancouver
Hirata AS, Branco PC, Rezende-Teixeira P, Jimenez PC, Clair JJL, Fenical W, Costa-Lotufo LV. Seriniquinone, metabolite from a marine bacterium, and its synthetic derivative for melanoma and resistant melanoma cells treatment [Internet]. Marine Drugs. 2020 ; 18( 1): 114.[citado 2024 nov. 14 ] Available from: https://doi.org/10.3390/md18010040
Artigo de periodico
Prediction of seriniquinone-drug interactions by in vitro inhibition of human cytochrome P450 enzymes (2020)
Silva, Rodrigo Moreira da ; Carrão, Daniel Blascke ; Habenschus, Maísa Daniela ; Jimenez, Paula Christine; Lopes, Norberto Peporine ; Fenical, William ; Costa-Lotufo, Letícia Veras ; Oliveira, Anderson Rodrigo Moraes de
Source: Toxicology in Vitro. Unidades: FCFRP, ICB, FFCLRP
Subjects: FARMACOLOGIA, METABOLISMO, METABÓLITOS SECUNDÁRIOS, BACTÉRIAS ANAERÓBICAS GRAM-POSITIVAS, CÉLULAS CULTIVADAS DE TUMOR, MELANOMA, METÁSTASE NEOPLÁSICA, MOLÉCULAS DE ADESÃO CELULAR, INIBIDORES DE ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Rodrigo Moreira da et al. Prediction of seriniquinone-drug interactions by in vitro inhibition of human cytochrome P450 enzymes. Toxicology in Vitro, v. 65, p. 10 , 2020Tradução . . Disponível em: https://doi.org/10.1016/j.tiv.2020.104820. Acesso em: 14 nov. 2024.
APA
Silva, R. M. da, Carrão, D. B., Habenschus, M. D., Jimenez, P. C., Lopes, N. P., Fenical, W., et al. (2020). Prediction of seriniquinone-drug interactions by in vitro inhibition of human cytochrome P450 enzymes. Toxicology in Vitro, 65, 10 . doi:10.1016/j.tiv.2020.104820
NLM
Silva RM da, Carrão DB, Habenschus MD, Jimenez PC, Lopes NP, Fenical W, Costa-Lotufo LV, Oliveira ARM de. Prediction of seriniquinone-drug interactions by in vitro inhibition of human cytochrome P450 enzymes [Internet]. Toxicology in Vitro. 2020 ; 65 10 .[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.tiv.2020.104820
Vancouver
Silva RM da, Carrão DB, Habenschus MD, Jimenez PC, Lopes NP, Fenical W, Costa-Lotufo LV, Oliveira ARM de. Prediction of seriniquinone-drug interactions by in vitro inhibition of human cytochrome P450 enzymes [Internet]. Toxicology in Vitro. 2020 ; 65 10 .[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.tiv.2020.104820
Artigo de periodico
Mass spectrometry analysis of protonated marine natural product seriniquinone (2018)
Silva, Rodrigo M. da; Guaratini, Thais; Jimenez, Paula C.; Fenical, William; Vessecchi, Ricardo; Lopes, Norberto Peporine; Costa-Lotufo, Letícia Veras
Source: Journal Brazilian Chemical Society. Unidades: FFCLRP, FCFRP, ICB
Subjects: COMPOSTOS AROMÁTICOS, METABÓLITOS, ESPECTROMETRIA DE MASSAS, IONIZAÇÃO DE GASES, BACTÉRIAS ANAERÓBICAS GRAM-POSITIVAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Rodrigo M. da et al. Mass spectrometry analysis of protonated marine natural product seriniquinone. Journal Brazilian Chemical Society, v. 29, n. 5, p. 1162-1166, 2018Tradução . . Disponível em: https://doi.org/10.21577/0103-5053.20180037. Acesso em: 14 nov. 2024.
APA
Silva, R. M. da, Guaratini, T., Jimenez, P. C., Fenical, W., Vessecchi, R., Lopes, N. P., & Costa-Lotufo, L. V. (2018). Mass spectrometry analysis of protonated marine natural product seriniquinone. Journal Brazilian Chemical Society, 29( 5), 1162-1166. doi:10.21577/0103-5053.20180037
NLM
Silva RM da, Guaratini T, Jimenez PC, Fenical W, Vessecchi R, Lopes NP, Costa-Lotufo LV. Mass spectrometry analysis of protonated marine natural product seriniquinone [Internet]. Journal Brazilian Chemical Society. 2018 ; 29( 5): 1162-1166.[citado 2024 nov. 14 ] Available from: https://doi.org/10.21577/0103-5053.20180037
Vancouver
Silva RM da, Guaratini T, Jimenez PC, Fenical W, Vessecchi R, Lopes NP, Costa-Lotufo LV. Mass spectrometry analysis of protonated marine natural product seriniquinone [Internet]. Journal Brazilian Chemical Society. 2018 ; 29( 5): 1162-1166.[citado 2024 nov. 14 ] Available from: https://doi.org/10.21577/0103-5053.20180037
Artigo de periodico
Elucidating the mode of action of marine natural products through an immunoaffinity fluorescent (IAF) approach (2016)
Clair, James J. La; Fenical, William; Costa-Lotufo, Letícia Veras
Source: Journal of the Braziliam Chemical Society. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CLAIR, James J. La e FENICAL, William e COSTA-LOTUFO, Letícia Veras. Elucidating the mode of action of marine natural products through an immunoaffinity fluorescent (IAF) approach. Journal of the Braziliam Chemical Society, v. 27, n. 8, p. 1346-1354, 2016Tradução . . Disponível em: https://doi.org/10.5935/0103-5053.20160148. Acesso em: 14 nov. 2024.
APA
Clair, J. J. L., Fenical, W., & Costa-Lotufo, L. V. (2016). Elucidating the mode of action of marine natural products through an immunoaffinity fluorescent (IAF) approach. Journal of the Braziliam Chemical Society, 27( 8), 1346-1354. doi:10.5935/0103-5053.20160148
NLM
Clair JJL, Fenical W, Costa-Lotufo LV. Elucidating the mode of action of marine natural products through an immunoaffinity fluorescent (IAF) approach [Internet]. Journal of the Braziliam Chemical Society. 2016 ; 27( 8): 1346-1354.[citado 2024 nov. 14 ] Available from: https://doi.org/10.5935/0103-5053.20160148
Vancouver
Clair JJL, Fenical W, Costa-Lotufo LV. Elucidating the mode of action of marine natural products through an immunoaffinity fluorescent (IAF) approach [Internet]. Journal of the Braziliam Chemical Society. 2016 ; 27( 8): 1346-1354.[citado 2024 nov. 14 ] Available from: https://doi.org/10.5935/0103-5053.20160148
Artigo de periodico-carta/editorial
Marine Natural Products (2015)
Lopes, Norberto P.; Rezende, Claudia M. R; Costa-Lotufo, Letícia Veras ; Fenical, William
Source: Revista Brasileira de Farmacognosia. Unidade: ICB
Subjects: FARMACOLOGIA, PRODUTOS NATURAIS, QUÍMICA AMBIENTAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, Norberto P. et al. Marine Natural Products. Revista Brasileira de Farmacognosia. Joao Pessoa: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.bjp.2015.09.004á. Acesso em: 14 nov. 2024. , 2015
APA
Lopes, N. P., Rezende, C. M. R., Costa-Lotufo, L. V., & Fenical, W. (2015). Marine Natural Products. Revista Brasileira de Farmacognosia. Joao Pessoa: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1016/j.bjp.2015.09.004á
NLM
Lopes NP, Rezende CMR, Costa-Lotufo LV, Fenical W. Marine Natural Products [Internet]. Revista Brasileira de Farmacognosia. 2015 ; 25( 6): 567-568.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.bjp.2015.09.004á
Vancouver
Lopes NP, Rezende CMR, Costa-Lotufo LV, Fenical W. Marine Natural Products [Internet]. Revista Brasileira de Farmacognosia. 2015 ; 25( 6): 567-568.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.bjp.2015.09.004á
Artigo de periodico
The hybrid pyrroloisoindolone-dehydropyrrolizine alkaloid (-)-chlorizidine a targets proteins within the glycolytic pathway (2015)
Álvarez-Micó, Xavier; Rocha, Danilo D.; Guimarães, Larissa A.; Ambrose, Andrew; Chapman, Eli; Costa-Lotufo, Letícia Veras ; Clair, James J. La; Fenical, William
Source: ChemBioChem. Unidade: ICB
Subjects: ALCALOIDES DE PIRROLIZIDINA, PROTEINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ÁLVAREZ-MICÓ, Xavier et al. The hybrid pyrroloisoindolone-dehydropyrrolizine alkaloid (-)-chlorizidine a targets proteins within the glycolytic pathway. ChemBioChem, v. 16, n. 14, p. 2002-2006, 2015Tradução . . Disponível em: https://doi.org/10.1002/cbic.201500229. Acesso em: 14 nov. 2024.
APA
Álvarez-Micó, X., Rocha, D. D., Guimarães, L. A., Ambrose, A., Chapman, E., Costa-Lotufo, L. V., et al. (2015). The hybrid pyrroloisoindolone-dehydropyrrolizine alkaloid (-)-chlorizidine a targets proteins within the glycolytic pathway. ChemBioChem, 16( 14), 2002-2006. doi:10.1002/cbic.201500229
NLM
Álvarez-Micó X, Rocha DD, Guimarães LA, Ambrose A, Chapman E, Costa-Lotufo LV, Clair JJL, Fenical W. The hybrid pyrroloisoindolone-dehydropyrrolizine alkaloid (-)-chlorizidine a targets proteins within the glycolytic pathway [Internet]. ChemBioChem. 2015 ; 16( 14): 2002-2006.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/cbic.201500229
Vancouver
Álvarez-Micó X, Rocha DD, Guimarães LA, Ambrose A, Chapman E, Costa-Lotufo LV, Clair JJL, Fenical W. The hybrid pyrroloisoindolone-dehydropyrrolizine alkaloid (-)-chlorizidine a targets proteins within the glycolytic pathway [Internet]. ChemBioChem. 2015 ; 16( 14): 2002-2006.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/cbic.201500229

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Funding Agencies

Indexado em

Non normalized affiliation